Navigation Links
China-Biotics, Inc. to Present at Two Upcoming Investor Conferences

SHANGHAI, China, May 14 /Xinhua-PRNewswire-FirstCall/ -- China-Biotics, Inc. (OTC Bulletin Board: CHBT) ("China-Biotics," "the Company"), a leading Chinese firm specializing in the manufacture, research, development, marketing and distribution of probiotics products, today announced the Company's management will present at two upcoming investor conferences: Brean Murray, Carret & Co.'s The All-Cap All-China Conference in New York City and the ROTH China Discovery Tour in Sanya, China.

The date, time and location of China-Biotics' presentations at these conferences are:

Brean Murray, Carret & Co.'s The All-Cap All-China Conference

Date: Monday, May 19, 2008

Time: 2:45 p.m. EDT

Venue: Jade Room

The Waldorf=Astoria

New York, NY

The conference will feature formal group presentations and one-on-one meetings with approximately 100 Chinese companies. The participating companies will span the market cap spectrum from large-cap companies to private, "soon-to-be-listed" companies. Interested parties and institutional investors may register for the conference by visiting the conference Web site at: 325.

The presentation will also be webcast live over the Internet and can be accessed by all interested parties at or the Company's Web site, .

ROTH China Discovery Tour 2008

Date: Friday, May 23, 2008

Time: 2:40 a.m. EDT

Venue: Chi Gu 2

Ritz-Carlton Hotel

Sanya, China

The 3rd Annual ROTH China Discovery Tour will feature more than 70 companies in seven cities throughout China, combining factory visits with management presentations in a mini-conference format. During the past two years, ROTH has taken investors on more than 60 company visits in mainland China and hosted close to 200 Chinese company presentations at its conferences. For more information about this invitation-only event, please contact

About China-Biotics, Inc.

Headquartered in Shanghai, China-Biotics, Inc. ("China-Biotics", "the Company") was founded in 1999 and is one of China's largest suppliers of probiotics. Probiotics are beneficial live bacteria used as dietary supplements and food additives to improve intestinal health and digestion. The Company's product portfolio contains live microbials made with proprietary technology. Currently, these products are sold over-the-counter under the "Shining" brand through large distributors to more than 1,000 pharmacies and 100 supermarkets in Shanghai, Jiangsu and Zhejiang. Shining is one of the most recognized brands in Shanghai. China-Biotics plans to expand its retail sales to other major cities in China and will launch 300 Shining brand logistic centers in these cities during the next two years. The Company's flagship product, "Shining Essence", has been a profit driver since its launch in April 2001. There is a significant demand for probiotics for use in the bulk additive market, which is currently met by imports. China-Biotics is building a new plant which will increase its production capacity manifolds to capture this market. For more information, please visit .

For more information, please contact:

CCG Elite Investor Relations

Crocker Coulson, President

Tel: +1-646-213-1915 (New York)



SOURCE China-Biotics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. China-Biotics, Inc. Completes Foundation for Its New Plant
2. China-Biotics, Inc. Reports Third Quarter 2008 Financial Results
3. China-Biotics, Inc. Announces Rescheduling of Conference Call to Discuss Third Quarter 2008 Results
4. China-Biotics, Inc. Launches English / Chinese Corporate and Investor Relations Web Site
5. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter FY 2008 Results
6. China-Biotics, Inc. Receives Approval to Begin Construction on Large-Scale Manufacturing Facility
7. China-Biotics, Inc. Launches Shining Probiotics Protein Powder
8. China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.
9. Novavax CEO to Present at ACUMENBioFins 5th Annual Global Healthcare Conference
10. Access Pharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
11. Interleukin Genetics to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference
Post Your Comments:
(Date:11/24/2015)... and NEW YORK , November 24, ... investment by Bristol-Myers Squibb in a European ... Bristol-Myers Squibb Company in which the companies will work ... immuno-oncology and other areas of unmet medical need. The collaboration ... LSP 5, the latest LSP fund. This is the first ...
(Date:11/24/2015)... , Nov. 24, 2015 According to two new ... 2005. This is something that many doctors, scientists, and public ... questions remains: with fewer PSA tests being done, will there ... Dr. David Samadi, "Despite the efforts made ... remains the second leading cancer cause of death in men, ...
(Date:11/23/2015)... Nov. 23, 2015   Ceres, Inc . (Nasdaq: ... financial results for the fiscal year ended August 31, ... --> --> During fiscal ... and feed products with a better balance of yield, ... distribution agreements with several leading crop input providers and ...
(Date:11/23/2015)... Md. (PRWEB) , ... November 23, 2015 , ... ... 100 award for the development of its Nexera UC Unified Chromatography system. The ... 100 most technically significant new products of the year in the analytical and ...
Breaking Biology Technology:
(Date:11/18/2015)... 18, 2015 --> ... new market report titled  Gesture Recognition Market - Global ... - 2021. According to the report, the global gesture recognition market was ... to reach US$29.1 bn by 2021, at a CAGR ... North America dominated the global gesture recognition ...
(Date:11/16/2015)... Calif. , Nov 16, 2015  Synaptics ... of human interface solutions, today announced expansion of ... TouchView ™ touch controller and display driver ... revolution of smartphones. These new TDDI products add ... TD4100 (HD resolution), TD4302 (WQHD resolution), and TD4322 ...
(Date:11/10/2015)... 10, 2015  In this report, the ... of product, type, application, disease indication, and ... report are consumables, services, software. The type ... biomarkers, efficacy biomarkers, and validation biomarkers. The ... diagnostics development, drug discovery and development, personalized ...
Breaking Biology News(10 mins):